Powerock Pharma Vitamin D3 + Vitamin K2 MK-7 20 000 IU + 300 µg 100 caps. 80 000 mcg
VITAMIN D3 + K2 MK-7 enhances bone mineralization and optimizes calcium metabolism through the synergistic action of cholecalciferol and menaquinone-7 – it protects the cardiovascular system and prevents arterial calcification. Choose Powerock Pharma for guaranteed purity ≥99.9% and proven research results.
VITAMIN D3 + K2 MK-7 20,000 IU + 300 µg 100 caps. 80,000 mcg
VITAMIN D3 + K2 MK-7 (Cholecalciferol + Menaquinone-7) is an advanced research compound designed for effective studies on calcium metabolism and bone health. This combination has been developed with effective regulation of calcium homeostasis and precise control of bone mineralization processes in mind. Its action is based on the synergistic effect of two key vitamins: D3 (cholecalciferol) and K2 MK-7 (menaquinone-7). This dual functionality makes VITAMIN D3 + K2 MK-7 widely applicable in research on osteoporosis, cardiovascular health, and metabolic disorders.
VITAMIN D3 + K2 MK-7 Powerock Pharma – Properties
Discover the potential laboratory properties of VITAMIN D3 + K2 MK-7 that may support research on calcium metabolism, bone health, and cardiovascular system health.
Bone Mineralization
Supports effective mineralization of bone tissue by optimizing calcium absorption.
Vascular Protection
Prevents unwanted arterial calcification by directing calcium to the appropriate tissues.
Homeostasis Regulation
Optimizes calcium homeostasis in the body by increasing bioavailability.
Dual Mechanism
Simultaneously activates vitamin D3 and K2 pathways for improved metabolic effects.
Immune Enhancement
Supports immune functions by modulating immune cell activity.
Metabolic Stabilization
Supports overall metabolic balance and muscle function.
High Research Quality
Manufactured in accordance with GMP, HACCP, and ISO 13485 standards.
Precise Action
Targeted action on vitamin receptors for optimal research results.
How VITAMIN D3 + K2 MK-7 Works
- Action of the Vitamin D3 and K2 MK-7 combination: is based on the synergistic mechanism of regulating calcium metabolism through simultaneous activation of the metabolic pathways of both vitamins.
- Increased calcium absorption: Vitamin D3 stimulates the synthesis of calcium-binding proteins, increasing its absorption from the digestive tract.
- Activation of vitamin K-dependent proteins: K2 MK-7 activates osteocalcin and matrix Gla-protein (MGP), directing calcium to bone tissues.
- Prevention of vascular calcification: MGP protects arteries from unwanted calcification, maintaining vessel elasticity.
- Positive impact on metabolic health: Optimizes bone mineral density and is a prime candidate for research on osteoporosis and cardiovascular diseases.
Why choose VITAMIN D3 + K2 MK-7 from Powerock Pharma?
At Powerock Pharma, the priority is to provide only the highest quality research substances. Every batch of Vitamin D3 + K2 MK-7 is manufactured in facilities compliant with GMP, HACCP, and ISO 13485 standards. Our strict quality control supervision and use of the latest HPLC testing procedures ensure not only product efficacy but also their safety and reliability. Collaboration with leading laboratories ensures purity ≥99.9% and effectiveness of substances, providing durable and repeatable results. By choosing Powerock Pharma, you opt for excellence, safety, and unmatched quality of research materials.
Research Protocol
How to research:
Vitamin D3 + K2 MK-7 should be administered orally, using prepared capsules with precisely measured concentration. For accurate calculation of research doses, we recommend using the research substance dose calculator.
When to administer:
For best results, it is recommended to administer at fixed times according to the research protocol or as required by the experiment.
Duration of one research cycle:
The suggested research period is 8–12 weeks for accurate monitoring of physiological effects and outcomes.
Recommended amount for model A:
For model A, an initial dose of 250 mcg Vitamin D3 + 150 mcg K2 MK-7 per serving is recommended, with the possibility of adjustment depending on research goals.
Recommended amount for model B:
For model B, the standard dose is 500 mcg Vitamin D3 + 300 mcg K2 MK-7 per serving, with modifications depending on research parameters.
Monitoring:
Continuous monitoring of research subjects is crucial for accurate data collection and rapid identification of any adverse effects. Regular testing of calcium, vitamin D, and K levels in serum is recommended.
Frequently Asked Questions
- The standard dose is 500 mcg Vitamin D3 + 300 mcg K2 MK-7 per capsule. Adjustments should be made based on research objectives and characteristics of the research subjects.
- Yes, Vitamin D3 + K2 MK-7 is often combined with magnesium glycinate, omega-3 fatty acids, coenzyme Q10, melatonin, and nootropic blends to achieve synergistic research benefits.
- Side effects are rare but may include mild gastrointestinal discomfort or changes in calcium levels. Regular monitoring of biochemical parameters is recommended.
- Current studies suggest a favorable safety profile when used as recommended, but continuous monitoring of vitamin and mineral status in the body is advised.
- Capsules should be stored at controlled room temperature (<25°C), protected from light and moisture to maintain stability and efficacy.
- Powerock Pharma ensures purity ≥99.9% (tested by HPLC), rigorous quality control, and compliance with GMP, HACCP, and ISO 13485 standards, guaranteeing reliability and consistency of research grade.
Calculator for measuring research doses
Tip: 1 MG = 1000 MCG